Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04692597 · ClinicalTrials.gov registry record · NA

Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.

A NA study, sponsored by David Moss.

Terminated
Registry status
NA
Development phase
83
Enrollment target

NCT04692597 is a NA study that was terminated before completion, run by David Moss. The registered enrollment target is 83 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04692597, a NA study, was terminated before completion, sponsored by David Moss.

TERMINATED
Registry status
NA
Development phase
83 participants
Enrollment target

Study Summary

This study is a randomized, control trial of Active Duty and DoD Beneficiaries, age 18 years or older, with complaints of hand osteoarthritis. Subjects will be randomized into one of two groups receiving either LLLT or sham LLLT. Subjects will receive LLLT or sham LLLT weekly over a period of six weeks. At each visit, patients will rate their pain using the Defense and Veterans Pain Rating Scale (DVPRS) and assess their functionality using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Subjects will have a follow up visit six weeks after the treatment protocol for a final assessment of pain and function. The Phoenix Thera-Lase laser is a Class II, 510k cleared device (#K151521) and is legally marketed in the US. Investigators are using in accordance with its approved labeling and no changes to the approved labeling are being sought.

Interventions

  • DEVICE Phoenix Thera-Lase System
  • DEVICE SHAM Phoenix Thera-Lase System

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2021-03-02
Est. Completion 2025-12-09
Phase NA

Sponsor

David Moss

7 total trials

What the Registry Record Tells You About NCT04692597

The ClinicalTrials.gov registry entry for NCT04692597 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Moss, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Phoenix Thera-Lase System is the first listed.

NCT04692597 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04692597 about?

NCT04692597 is a clinical study titled "Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.". This study is a randomized, control trial of Active Duty and DoD Beneficiaries, age 18 years or older, with complaints of hand osteoarthritis. Subjects will be randomized into one of two groups receiving either LLLT or sham LLLT. Subjects will receive LLLT or sham LLLT weekly over a period of six we...

What is the current status of trial NCT04692597?

This trial is currently terminated. It is a NA study. The enrollment target is 83 participants. The study started on 2021-03-02. Estimated completion is 2025-12-09.

What interventions are being tested in trial NCT04692597?

The interventions under investigation include: Phoenix Thera-Lase System (DEVICE), SHAM Phoenix Thera-Lase System (DEVICE).

Who is sponsoring clinical trial NCT04692597?

This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.